3-dimensional (3d) structures of three coumarin derivatives (c30, c30-me, and smsm64) (Chembio Diagnostics)
Structured Review
![Coumarin <t>derivatives</t> can selectively bind to RNA G 1 × 0 bulges: ( A ) RNA structures of the 1 × 0 RNA bulges used for in vitro binding profiling using the FP assay. N = G , A , U , or C (RNA1-4). ( B ) Heatmap profile of the ΔmP = (FP RNA-ligand – FP ligand ) × 1000 for RNA binders in the presence of [RNA] = 5 or 1 μM (red = high polarization, blue = low polarization). ( C ) ΔmP of RNA-ligand complex for RNA ligands at 5 μM. Each data point represents a measurement of a ligand in the 69-compound collection. **** indicates P < .0001. ( D ) Dose-response curves for compounds (SMSM6, <t>C30)</t> selectively binding to the bulged G RNA (RNA1) compared to an 11-nucleotide GA-rich sequence that would form a double loop-like RNA structure measured by the FP assay.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8297/pmc12188297/pmc12188297__gkaf559fig2.jpg)
3 Dimensional (3d) Structures Of Three Coumarin Derivatives (C30, C30 Me, And Smsm64), supplied by Chembio Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/three-dimensional+structures/3+dimensional++3d++structures+of+three+coumarin+derivatives++c30++c30+me++and+smsm64+/pmc12188297-55-5-14
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Mechanistic studies of small molecule ligands selective to RNA single G bulges"
Article Title: Mechanistic studies of small molecule ligands selective to RNA single G bulges
Journal: Nucleic Acids Research
doi: 10.1093/nar/gkaf559
Figure Legend Snippet: Coumarin derivatives can selectively bind to RNA G 1 × 0 bulges: ( A ) RNA structures of the 1 × 0 RNA bulges used for in vitro binding profiling using the FP assay. N = G , A , U , or C (RNA1-4). ( B ) Heatmap profile of the ΔmP = (FP RNA-ligand – FP ligand ) × 1000 for RNA binders in the presence of [RNA] = 5 or 1 μM (red = high polarization, blue = low polarization). ( C ) ΔmP of RNA-ligand complex for RNA ligands at 5 μM. Each data point represents a measurement of a ligand in the 69-compound collection. **** indicates P < .0001. ( D ) Dose-response curves for compounds (SMSM6, C30) selectively binding to the bulged G RNA (RNA1) compared to an 11-nucleotide GA-rich sequence that would form a double loop-like RNA structure measured by the FP assay.
Techniques Used: In Vitro, Binding Assay, FP Assay, Sequencing
Figure Legend Snippet: Protonation state of the ligands contributes to the RNA binding. ( A ) Equilibria for the protonation reactions of four coumarin derivatives. ( B ) Protonation energy (relative to C29) was calculated using DFT with B3LYP 6–31G(d) basis set. ( C ) Observed binding affinity of the four compounds.
Techniques Used: RNA Binding Assay, Binding Assay
Related Articles
Construct:Article Title: Discovery of novel PARP/PI3K dual inhibitors with high efficiency against BRCA-proficient triple negative breast cancer. Article Snippet: Co-targeting PARP and PI3K by PARP/PI3K dual inhibitors has been recognized as a promising chemotherapeutic strategy for the treatment of triple negative breast cancer (TNBC) in our previous work.. To further explore novel and more potent PARP/PI3K dual inhibitors, a series of compounds were designed, synthesized and evaluated for their pharmacological properties, resulting in the candidate compound 12, a potent and highly selective PARP/PI3K dual inhibitor.. Compared to Olaparib, compound 12 exhibits a superior antiproliferative profile against BRCA-proficient MDA-MB-468 cells. Software:Article Title: Discovery of novel PARP/PI3K dual inhibitors with high efficiency against BRCA-proficient triple negative breast cancer. Article Snippet: Co-targeting PARP and PI3K by PARP/PI3K dual inhibitors has been recognized as a promising chemotherapeutic strategy for the treatment of triple negative breast cancer (TNBC) in our previous work.. To further explore novel and more potent PARP/PI3K dual inhibitors, a series of compounds were designed, synthesized and evaluated for their pharmacological properties, resulting in the candidate compound 12, a potent and highly selective PARP/PI3K dual inhibitor.. Compared to Olaparib, compound 12 exhibits a superior antiproliferative profile against BRCA-proficient MDA-MB-468 cells. other:Article Title: Design, Synthesis and Preliminary Biological Evaluation of Benzylsulfone Coumarin Derivatives as Anti-Cancer Agents Article Snippet: The three-dimensional structures of compounds 5h and 5m were built using Article Title: Glycyrrhizic acid and patchouli alcohol in Huoxiang Zhengqi attenuate intestinal inflammation and barrier injury via regulating endogenous corticosterone metabolism mediated by 11β-HSD1. Article Snippet: Please cite this article as: Wang, Y., Sun, C., Cao, Y., Jiao, T., Wang, K., Li, J., Zhang, M., Jiang, J., Zhong, X., Yu, S., Xu, H., Wang, J., Yi, T., Tian, X., Zhu, H., Zhou, H., Huang, C., Wu, T., Guo, X., Xie, C., Glycyrrhizic acid and patchouli alcohol in Huoxiang Zhengqi attenuate intestinal inflammation and barrier injury via regulating endogenous corticosterone metabolism mediated by 11β-HSD1, Journal of Ethnopharmacology, https://doi.org/10.1016/j.jep.2024.119025. Article Title: Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors Article Snippet: The three-dimensional structures of the compounds 12a – s were constructed using Article Title: Investigating the Activity of Indole-2-on Derivative Src Kinase Inhibitors Against Chronic Myeloid Leukemia Cells. Article Snippet: Background: Src family tyrosine kinases play a potential role in Bcr-Abl-induced leukemogenesis.. Src kinase inhibitors are reported as selective inhibitors of chronic myeloid leukemia.. Objective: Since Src kinase inhibitors have an inhibitive effect on chronic myeloid leukemia, indole derivatives (C-1, C-2, C-3) previously found as potent inhibitors of Src kinase were tested against chronic myeloid leukemia in this Article Title: Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer Article Snippet: The three-dimensional structures of the compounds iBAP and iBAP-II were constructed using Article Title: Network pharmacology and molecular docking study on the potential mechanism of Tongqiao–Biyan granule in treatment of allergic rhinitis Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82271146, 82271147; Major Scientific and Technological Innovation Project of Shandong Province, Grant/Award Number: 2022CXGC020506 Abstract Purpose: Allergic rhinitis (AR) is a pervasive global health problem, imposing a major economic burden and causing disability worldwide.. Tongqiao–Biyan granule (TBG) has gained popularity in China for the treatment of AR.. This study aimed to elucidate the molecular mechanism underlying TBG's efficacy in treating AR. Article Title: Thienopyrimidine-Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer Cells. Article Snippet: Apoptotic evasion by cancerous cells being one of the striking hallmarks of cancer has turned into a new arena of drug discovery.. A large number of pathways reported that govern the apoptotic evasion have been reported.. Fas-activated serine/threonine kinase (FASTK) is a member of Ser/Thr kinase family, and it has been implicated in the apoptotic evasion and, hence, the development of cancer. |
